Skip to main content
Log in

Percutaneous mitoxantrone injection for primary and secondary liver tumors: Preliminary results

  • Clinical Investigations
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Purpose: To determine the effects of percutaneous intratumoral chemotherapy with mitoxantrone (PIM) in the palliative treatment of malignant liver lesions.

Methods: We treated 15 progressive lesions in nine patients in whom either previous therapy failed or serious complications developed as a result. Seven lesions were metastatic and eight were due to foci of hepatocellular carcinoma. Under computed tomography (CT) guidance, we percutaneously injected 10–20 mg of mitoxantrone mixed with 0.5 ml of contrast medium into the tumor, performing one to three treatments at intervals of 1 month.

Results: There were no complications. The morphologic responses of the tumors after treatment were: minor response in one case, no change in 11 cases, progressive disease in three cases. Mitoxantrone induced tumor necrosis with no viable cancer tissue in eight of 11 biopsies. Recurrence was observed in nine of the treated lesions 2–9 months after treatment. New lesions were observed in five of nine patients 1–9 months after treatment.

Conclusion: In patients with malignant liver lesions with no other therapeutic possibilities, minimally invasive intratumoral mitoxantrone injection was carried out safely with good tumor delivery of chemotherapy, and tumor necrosis was demonstrated at biopsy. We feel this approach warrants further investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Shiina S, Tagawa K, Niwa Y, Unuma T, Komatsu Y, Yoshiura K, Hamada E, Takahashi M, Shiratori Y, Terano A, et al. (1993) Percutaneous ethanol injection therapy for hepatocellular hepatocarcinoma: Results in 146 patients. AJR 160:1023–1028

    PubMed  CAS  Google Scholar 

  2. Livraghi T, Giorgio A, Marin G, Salmi A, de Sio I, Bolondi L, Pompili M, Brunello F, Lazzaroni S, Torzilli G, et al. (1995) Hepatocellular carcinoma and cirrhosis in 746 patients: Long-term results of percutaneous ethanol injection. Radiology 197:101–108

    PubMed  CAS  Google Scholar 

  3. Tanaka K, Nakamura S, Numata K, Okazaki H, Endo O, Inoue S, Takamura Y, Sugiyama M, Ohaki Y (1992) Hepatocellular carcinoma: Treatment with percutaneous ethanol injection and transcatheter arterial embolization. Radiology 185:457–460

    PubMed  CAS  Google Scholar 

  4. Zamboglou N, Wurm R, Pape H, Schnabel TH, Kuhn FP, Streffer C, Schmitt G (1991) Simultaneous radiotherapy and intratumoral instillation of mitoxantrone in locoregional recurrence of head and neck carcinoma. Reg Cancer Treat 4:79–84

    Google Scholar 

  5. Fox ME, Smith PJ (1995) Subcellular localisation of the antitumour drug mitoxantrone and the induction of DNA damage in resistant and sensitive human colon carcinoma cells. Cancer Chemother Pharmacol 35:403–410

    Article  PubMed  CAS  Google Scholar 

  6. Markman M, Alberts D, Rubin S, Hakes T, Lewis JL Jr, Reichman B, Jones W, Curtin J, Barakat R, Brodar F, et al. (1993) Evidence for persistence of mitoxantrone within the peritoneal cavity following intraperitoneal delivery. Gynecol Oncol 48:185–188

    Article  PubMed  CAS  Google Scholar 

  7. Ramirez LH, Zhao Z, Rougier P, Bognel C, Dzodic R, Vassal G, Ardouin P, Gouyette A, Munck JN (1996) Pharmacokinetics and antitumor effects of mitoxantrone after intratumoral or intraarterial hepatic administration in rabbits. Cancer Chemoth Pharmacol 37:371–376

    Article  CAS  Google Scholar 

  8. Farmer DG, Rosove MH, Shaked A, Busutil RW (1994) Current treatment modalities for hepatocellular carcinoma. Ann Surg 81:1563–1571

    Google Scholar 

  9. Weimann A, Oldhaier KJ, Pichlmayr R (1995) Primary liver cancer. Curr Opin Oncol 7:387–396

    Article  PubMed  CAS  Google Scholar 

  10. Groupe d’etude et de traitement du carcinome hépatocellulaire (1995) A comparison of Lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332:1256–1261

    Article  Google Scholar 

  11. Chung JW, Park JH, Han JK, Choi BI, Han MC, Lee HS, Kim CY (1996) Hepatic tumors: Predisposing factors for complications of transcatheter oil chemoembolization. Radiology 198:33–40

    PubMed  CAS  Google Scholar 

  12. Livraghi T, Vettori C, Lazzaroni S (1991) Liver metastases: Results of percutaneous ethanol injection in 14 patients. Radiology 179:709–712

    PubMed  CAS  Google Scholar 

  13. Honda N, Guo Q, Uchida H, Ohishi H, Hiasa Y (1991) Percutaneous hot saline injection therapy for hepatic tumors: An alternative to percutaneous ethanol injection therapy. Radiology 190:53–57

    Google Scholar 

  14. Ohnishi K, Ohyama O, Ito S, Fujiwara K (1994) Small hepatocellular carcinoma: Treatment with US-guided intratumoral injection of acetic acid. Radiology 193:747–752

    PubMed  CAS  Google Scholar 

  15. Hoffmann W, Reichel H, Schiebe M, Bültmann B, Bamberg M (1993) Intrapericardial instillation of mitoxantrone in malignant pericarditis: Histomorphological appearance. Reg Cancer Treat 2:91–99

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Farrés, M.T., Baere, T.d., Lagrange, C. et al. Percutaneous mitoxantrone injection for primary and secondary liver tumors: Preliminary results. Cardiovasc Intervent Radiol 21, 399–403 (1998). https://doi.org/10.1007/s002709900287

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002709900287

Key words

Navigation